These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 10503876

  • 1. Antitumor activity of a novel ginseng saponin metabolite in human pulmonary adenocarcinoma cells resistant to cisplatin.
    Lee SJ, Sung JH, Lee SJ, Moon CK, Lee BH.
    Cancer Lett; 1999 Sep 20; 144(1):39-43. PubMed ID: 10503876
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS, Jung HY, Yang SK, Kim HR, Min YI.
    Anticancer Res; 1997 Sep 20; 17(5A):3613-6. PubMed ID: 9413212
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
    Fukuda M, Ohe Y, Kanzawa F, Oka M, Hara K, Saijo N.
    Anticancer Res; 1995 Sep 20; 15(2):393-8. PubMed ID: 7763011
    [Abstract] [Full Text] [Related]

  • 4. Induction of apoptosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 protease.
    Lee SJ, Ko WG, Kim JH, Sung JH, Moon CK, Lee BH.
    Biochem Pharmacol; 2000 Sep 01; 60(5):677-85. PubMed ID: 10927026
    [Abstract] [Full Text] [Related]

  • 5. In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.
    Lee YS, Nishio K, Ogasawara H, Funayama Y, Ohira T, Saijo N.
    Cancer Res; 1995 Mar 01; 55(5):1075-9. PubMed ID: 7866991
    [Abstract] [Full Text] [Related]

  • 6. In vitro cytotoxicity, pharmacokinetics and ex vivo pharmacodynamics of a new platinum compound, cis-malonato [(4R,5R-4,5-bis(aminomethyl)-1,3-dioxolane-2-spiro-1'-cyclopentane] platinum (II).
    Kim DK, Kim HT, Cho YB, Kim TS, Kim KH, Hong WS.
    Anticancer Res; 1996 Mar 01; 16(1):251-6. PubMed ID: 8615617
    [Abstract] [Full Text] [Related]

  • 7. Non-cross resistance of ZD0473 in acquired cisplatin-resistant lung cancer cell lines.
    Kawamura-Akiyama Y, Kusaba H, Kanzawa F, Tamura T, Saijo N, Nishio K.
    Lung Cancer; 2002 Oct 01; 38(1):43-50. PubMed ID: 12367792
    [Abstract] [Full Text] [Related]

  • 8. Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.
    Kasahara K, Fujimura M, Bando T, Shibata K, Shirasaki H, Matsuda T.
    Br J Cancer; 1996 Nov 01; 74(10):1553-8. PubMed ID: 8932334
    [Abstract] [Full Text] [Related]

  • 9. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
    Zhang MC, Hu CP, Chen Q.
    Zhonghua Zhong Liu Za Zhi; 2006 Jun 01; 28(6):408-12. PubMed ID: 17152483
    [Abstract] [Full Text] [Related]

  • 10. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
    Perez EA, Hack FM, Webber LM, Chou TC.
    Cancer Chemother Pharmacol; 1993 Jun 01; 33(3):245-50. PubMed ID: 8269606
    [Abstract] [Full Text] [Related]

  • 11. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
    Hu S, Hu CP, Liang CH.
    Zhonghua Yi Xue Za Zhi; 2005 Jun 08; 85(21):1493-8. PubMed ID: 16061030
    [Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y, Nakagawa K, Fujiwara Y, Sasaki Y, Minato K, Bungo M, Niimi S, Horichi N, Fukuda M, Saijo N.
    Cancer Res; 1989 Aug 01; 49(15):4098-102. PubMed ID: 2472873
    [Abstract] [Full Text] [Related]

  • 13. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ, Yu C, Yang Z, He JL, Chen WJ, Yin J, Li WM, Liu HT, Wang YX.
    Mol Med Rep; 2011 Aug 01; 4(5):985-92. PubMed ID: 21687949
    [Abstract] [Full Text] [Related]

  • 14. Biochemical characterization of cisplatin-resistance in MKN-45 human stomach adenocarcinoma cell line.
    Hong WS, Son YS.
    Anticancer Res; 1996 Aug 01; 16(5A):3031-6. PubMed ID: 8917423
    [Abstract] [Full Text] [Related]

  • 15. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
    Wang HJ, Yang ZX, Dai XT, Chen YF, Yang HP, Zhou XD.
    Apoptosis; 2017 Sep 01; 22(9):1157-1168. PubMed ID: 28677094
    [Abstract] [Full Text] [Related]

  • 16. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y, Jiang Z, Zhang Z, Sun N, Zhang M, Xie J, Li T, Hou Y, Wu D.
    J Cell Biochem; 2014 Jun 01; 115(6):1112-21. PubMed ID: 24356998
    [Abstract] [Full Text] [Related]

  • 17. Radiation sensitivities in various anticancer-drug-resistant human lung cancer cell lines and mechanism of radiation cross-resistance in a cisplatin-resistant cell line.
    Oshita F, Fujiwara Y, Saijo N.
    J Cancer Res Clin Oncol; 1992 Jun 01; 119(1):28-34. PubMed ID: 1400562
    [Abstract] [Full Text] [Related]

  • 18. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK, Zhang Y, Zhang ZJ, Qiu QW, Cao JG, He ZM.
    Oncol Rep; 2015 Jan 01; 33(1):372-82. PubMed ID: 25394854
    [Abstract] [Full Text] [Related]

  • 19. EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations.
    Gao J, Meng Q, Zhao Y, Chen X, Cai L.
    BMC Cancer; 2016 Jul 13; 16():470. PubMed ID: 27411790
    [Abstract] [Full Text] [Related]

  • 20. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
    Hida T, Ueda R, Takahashi T, Watanabe H, Kato T, Suyama M, Sugiura T, Ariyoshi Y, Takahashi T.
    Cancer Res; 1989 Sep 01; 49(17):4785-90. PubMed ID: 2547517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.